SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon - Quaterly Results

14 Feb 2023 Evaluate
A fair growth of 17.34% in the revenue at Rs. 5550.00 millions was reported in the December 2022 quarter as compared to Rs. 4730.00 millions during year-ago period.Net Profit recorded in the quarter ended December 2022 rise to 38.04% to Rs. 352.00  millions  compared to R. 255.00 millions in corresponding previous quarter.Operating profit surged to 970.00 millions from the corresponding previous quarter of 710.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 5550.00 4730.00 17.34 14862.00 12205.00 21.77 17382.00 20284.00 -14.31
Other Income 599.00 367.00 63.22 2074.00 1264.00 64.08 1872.00 1502.00 24.63
PBIDT 970.00 710.00 36.62 2749.00 1610.00 70.75 2483.00 4627.00 -46.34
Interest 214.00 1.00 21300.00 215.00 4.00 5275.00 4.00 4.00 0.00
PBDT 756.00 709.00 6.63 12626.00 1606.00 686.18 2479.00 4623.00 -46.38
Depreciation 291.00 276.00 5.43 875.00 801.00 9.24 1082.00 1035.00 4.54
PBT 465.00 433.00 7.39 11751.00 805.00 1359.75 1397.00 3588.00 -61.06
TAX 113.00 178.00 -36.52 1375.00 325.00 323.08 536.00 783.00 -31.55
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 352.00 255.00 38.04 10376.00 480.00 2061.67 861.00 2805.00 -69.30
Equity 6003.00 6003.00 0.00 6003.00 6003.00 0.00 6003.00 6000.00 0.05
PBIDTM(%) 17.48 15.01 16.43 18.50 13.19 40.22 14.28 22.81 -37.38

Biocon Share Price

380.55 -2.05 (-0.54%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×